Form 4: Modular Medical Director Ellen O'Connor Vos Granted Stock Options

Director Ellen O'Connor Vos receives fully vested stock options from Modular Medical, Inc.

Summary

• On December 31, 2024, Ellen O'Connor Vos, a director of Modular Medical, Inc., was granted an option to purchase 7,500 shares of common stock.
• The exercise price of the option is $1.39 per share.
• The option was granted under the Issuer's Outside Director Compensation Plan and was fully vested and exercisable on the grant date.
• The option expires on December 31, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed as a positive sign of aligning director interests with shareholders.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The options are fully vested immediately, incentivizing the director to contribute to the company's success from day one.

Industry Context

Granting stock options to directors is a common practice to align their interests with those of shareholders and incentivize them to contribute to the company's long-term success.

Comparison to Industry Standards

• Stock option grants to outside directors are a standard component of compensation packages in the biotech and medical device industries.
• Companies like Insulet and Dexcom also utilize stock options as part of their director compensation plans.
• The size of the grant (7,500 shares) should be compared to grants made by peer companies to directors with similar roles and responsibilities.

Stakeholder Impact

• Shareholders may view the option grant as a positive sign, aligning the director's interests with the company's success.
• The director is incentivized to contribute to the company's growth and profitability.

Key Dates